These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 821792

  • 1. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)].
    Takahara J, Ogawa N, Hosogi H, Aoki Y, Yamauchi J.
    Nihon Naibunpi Gakkai Zasshi; 1975 Oct 20; 51(10):803-12. PubMed ID: 821792
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
    Cantalamessa L, Reschini E, Catania A, Giustina G.
    Acta Endocrinol (Copenh); 1976 Dec 20; 83(4):673-83. PubMed ID: 826061
    [Abstract] [Full Text] [Related]

  • 6. Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.
    Matsukura S, Kakita T, Hirata Y, Yoshimi H, Fukase M.
    J Clin Endocrinol Metab; 1977 Feb 20; 44(2):392-7. PubMed ID: 190256
    [Abstract] [Full Text] [Related]

  • 7. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
    Jeppsson S, Nilsson KO, Rannevik G, Wide L.
    Acta Endocrinol (Copenh); 1976 Jun 20; 82(2):246-53. PubMed ID: 818858
    [Abstract] [Full Text] [Related]

  • 8. [The correlationship between basal prolactin levels and the suppressive effect of CB-154 or L-DOPA on GH release in acromegalic patients (author's transl)].
    Hara I, Kataoka K, Tomita A, Takanohashi M, Nakane T, Kuwayama A, Kageyama N.
    Nihon Naibunpi Gakkai Zasshi; 1979 Jan 20; 55(1):16-24. PubMed ID: 581754
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of synthetic ovine corticotropin-releasing factor on growth hormone secretion in patients with acromegaly.
    Tanaka K, Watabe T, Yoshida H, Shimizu N.
    Endocrinol Jpn; 1984 Jun 20; 31(3):355-61. PubMed ID: 6094167
    [Abstract] [Full Text] [Related]

  • 12. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
    Müller EE, Salerno F, Cocchi D, Locatelli V, Panerai AE.
    Clin Endocrinol (Oxf); 1979 Dec 20; 11(6):645-56. PubMed ID: 119594
    [Abstract] [Full Text] [Related]

  • 13. Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly.
    Hanew K, Sato S, Sasaki A, Shimizu Y, Murakami O, Yoshinaga K.
    Tohoku J Exp Med; 1985 Feb 20; 145(2):161-6. PubMed ID: 2859672
    [Abstract] [Full Text] [Related]

  • 14. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
    Tokuyama T, Yoshinari M, Okamura K, Ikenoue H, Sato K, Kuroda T, Fujishima M.
    Nihon Naibunpi Gakkai Zasshi; 1991 Feb 20; 67(2):65-74. PubMed ID: 1674920
    [Abstract] [Full Text] [Related]

  • 15. Differences in autonomity of growth hormone secretion in patients with acromegaly.
    Hanew K, Aida M, Tano T, Ojima M, Nishizato K.
    Tohoku J Exp Med; 1976 Oct 20; 120(2):159-67. PubMed ID: 824758
    [Abstract] [Full Text] [Related]

  • 16. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
    Utsumi A, Hanew K, Sugawara A, Shimizu Y, Murakami O, Ikeda H, Yoshinaga K.
    J Endocrinol Invest; 1992 Mar 20; 15(3):167-71. PubMed ID: 1624675
    [Abstract] [Full Text] [Related]

  • 17. [Endocrinological evaluation of sellar and suprasellar tumor cases (the eighth report)--on growth hormone secretion of acromegalic patients before treatment (author's transl)].
    Mori S, Uozumi T, Watanabe M, Takimoto N, Mogami H.
    No Shinkei Geka; 1976 Jul 20; 4(7):649-61. PubMed ID: 986015
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of the growth hormone response to vasoactive intestinal peptide and gonadotropin-releasing hormone in acromegaly.
    Watanobe H, Tamura T.
    Neuropeptides; 1995 Feb 20; 28(2):115-24. PubMed ID: 7746355
    [Abstract] [Full Text] [Related]

  • 19. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.
    Shibasaki T, Hotta M, Masuda A, Imaki T, Obara N, Hizuka N, Takano K, Wakabayashi I, Demura H, Ling N.
    J Clin Endocrinol Metab; 1986 Jul 20; 63(1):167-73. PubMed ID: 2872226
    [Abstract] [Full Text] [Related]

  • 20. [Reevaluation of the I-dopa test in acromegaly: anatomo-clinical and prognostic correlations].
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Iacona T, Conte G, Fabrizi ML, Valle D, Anile C, Maira G.
    Minerva Chir; 1993 Nov 20; 48(21-22):1337-40. PubMed ID: 8152567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.